Thomas Vanhove

911 total citations
24 papers, 678 citations indexed

About

Thomas Vanhove is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Thomas Vanhove has authored 24 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Transplantation, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Surgery. Recurrent topics in Thomas Vanhove's work include Renal Transplantation Outcomes and Treatments (18 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Transplantation: Methods and Outcomes (5 papers). Thomas Vanhove is often cited by papers focused on Renal Transplantation Outcomes and Treatments (18 papers), Pharmacological Effects and Toxicity Studies (10 papers) and Transplantation: Methods and Outcomes (5 papers). Thomas Vanhove collaborates with scholars based in Belgium, United States and Netherlands. Thomas Vanhove's co-authors include Dirk Kuypers, Pieter Annaert, Roel Goldschmeding, Evelyne Lerut, Tom Vermeulen, Henriëtte de Loor, Hylke de Jonge, Robin Vos, Isabel Spriet and Quinten Remijsen and has published in prestigious journals such as Transplantation, Clinical Pharmacology & Therapeutics and American Journal of Transplantation.

In The Last Decade

Thomas Vanhove

21 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Vanhove Belgium 13 402 197 183 107 91 24 678
A.-É. Heng France 9 504 1.3× 193 1.0× 263 1.4× 75 0.7× 52 0.6× 18 661
F. Villemain France 8 611 1.5× 208 1.1× 175 1.0× 77 0.7× 127 1.4× 13 757
Jean-Christophe Szelag France 9 432 1.1× 88 0.4× 140 0.8× 88 0.8× 147 1.6× 15 652
Mercidita T. Navarro United States 9 646 1.6× 238 1.2× 145 0.8× 93 0.9× 179 2.0× 16 810
Suwasin Udomkarnjananun Thailand 14 165 0.4× 188 1.0× 61 0.3× 162 1.5× 135 1.5× 64 674
M. Büchler France 13 295 0.7× 176 0.9× 116 0.6× 31 0.3× 88 1.0× 38 722
Agnes Lo United States 17 405 1.0× 336 1.7× 89 0.5× 47 0.4× 78 0.9× 25 662
Anne Maisin France 15 268 0.7× 81 0.4× 147 0.8× 41 0.4× 80 0.9× 39 601
Andy Nicholls United Kingdom 8 561 1.4× 129 0.7× 149 0.8× 85 0.8× 113 1.2× 11 778
Maria Welsh United States 13 626 1.6× 301 1.5× 369 2.0× 55 0.5× 50 0.5× 18 865

Countries citing papers authored by Thomas Vanhove

Since Specialization
Citations

This map shows the geographic impact of Thomas Vanhove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Vanhove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Vanhove more than expected).

Fields of papers citing papers by Thomas Vanhove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Vanhove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Vanhove. The network helps show where Thomas Vanhove may publish in the future.

Co-authorship network of co-authors of Thomas Vanhove

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Vanhove. A scholar is included among the top collaborators of Thomas Vanhove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Vanhove. Thomas Vanhove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vanhove, Thomas, David Wojciechowski, & Hannah Gilligan. (2025). Immunosuppression Minimization in Belatacept-Treated Kidney Transplant Recipients Guided by Combined Cell-Free DNA and Blood Gene Expression Monitoring. Transplantation Proceedings. 57(10). 1920–1924.
2.
Vanhove, Thomas, Nahel Elias, Kassem Safa, et al.. (2022). Long-term Outcome Reporting in Older Kidney Transplant Recipients and the Limitations of Conventional Survival Metrics. Kidney International Reports. 7(11). 2397–2409. 4 indexed citations
3.
Loor, Henriëtte de, Thomas Vanhove, Pieter Annaert, Eveline Lescrinier, & Dirk Kuypers. (2021). Determination of tacrolimus, three mono-demethylated metabolites and a M1 tautomer in human whole blood by liquid chromatography – tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 205. 114296–114296. 7 indexed citations
4.
Falke, Lucas L., Tri Q. Nguyen, Marianne C. Verhaar, et al.. (2019). Histological characteristics of Acute Tubular Injury during Delayed Graft Function predict renal function after renal transplantation. Physiological Reports. 7(5). e14000–e14000. 26 indexed citations
5.
Vanhove, Thomas, Hylke de Jonge, Henriëtte de Loor, et al.. (2018). Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers. Drug Metabolism and Disposition. 46(11). 1507–1513. 17 indexed citations
6.
Vanhove, Thomas, Pieter Annaert, Noël Knops, et al.. (2018). In vivoCYP3A4 activity does not predict the magnitude of interaction between itraconazole and tacrolimus from an extended release formulation. Basic & Clinical Pharmacology & Toxicology. 124(1). 50–55. 4 indexed citations
7.
Vanhove, Thomas, Mahmoud Hasan, Pieter Annaert, Stefan Oswald, & Dirk Kuypers. (2017). Pretransplant 4β‐hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation. British Journal of Clinical Pharmacology. 83(11). 2406–2415. 8 indexed citations
8.
Meijers, Björn, Christoph Metalidis, Thomas Vanhove, et al.. (2017). A noninferiority trial comparing a heparin-grafted membrane plus citrate-containing dialysate versus regional citrate anticoagulation: results of the CiTED study. Nephrology Dialysis Transplantation. 32(4). 707–714. 23 indexed citations
9.
Bellon, Hannelore, Elly Vandermeulen, Stijn E. Verleden, et al.. (2017). The Effect of Immunosuppression on Airway Integrity. Transplantation. 101(12). 2855–2861. 4 indexed citations
10.
Vanhove, Thomas, Thomas Bouillon, Henriëtte de Loor, Pieter Annaert, & Dirk Kuypers. (2017). Fexofenadine, a PutativeIn VivoP‐glycoprotein Probe, Fails to Predict Clearance of the Substrate Tacrolimus in Renal Recipients. Clinical Pharmacology & Therapeutics. 102(6). 989–996. 10 indexed citations
12.
Vanhove, Thomas, Hanneke Bouwsma, Luuk B. Hilbrands, et al.. (2017). Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients. American Journal of Transplantation. 17(9). 2372–2380. 68 indexed citations
13.
Bellon, Hannelore, Elly Vandermeulen, Anke Van Herck, et al.. (2017). Polymorphisms in immunosuppression transporters affect outcome after lung transplantation. Transplantation. PA1560–PA1560.
14.
Vanhove, Thomas, Pieter Annaert, & Dirk Kuypers. (2016). Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. Drug Metabolism Reviews. 48(1). 88–112. 114 indexed citations
15.
Vanhove, Thomas, Tom Vermeulen, Pieter Annaert, Evelyne Lerut, & Dirk Kuypers. (2016). High Intrapatient Variability of Tacrolimus Concentrations Predicts Accelerated Progression of Chronic Histologic Lesions in Renal Recipients. American Journal of Transplantation. 16(10). 2954–2963. 98 indexed citations
16.
Vanhove, Thomas, Pieter Annaert, Diether Lambrechts, & Dirk Kuypers. (2016). Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype. The Pharmacogenomics Journal. 17(6). 556–562. 17 indexed citations
17.
Vanhove, Thomas, Quinten Remijsen, Dirk Kuypers, & Pieter Gillard. (2016). Drug–drug interactions between immunosuppressants and antidiabetic drugs in the treatment of post-transplant diabetes mellitus. Transplantation Reviews. 31(2). 69–77. 42 indexed citations
18.
Vanhove, Thomas, Roel Goldschmeding, & Dirk Kuypers. (2016). Kidney Fibrosis. Transplantation. 101(4). 713–726. 71 indexed citations
19.
Jonge, Hylke de, Thomas Vanhove, Henriëtte de Loor, Kristin Verbeke, & Dirk Kuypers. (2015). Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit. British Journal of Clinical Pharmacology. 80(3). 548–559. 42 indexed citations
20.
Vandenput, Ingrid, Thomas Vanhove, Ben Van Calster, et al.. (2010). The Use of Lymph Vessel Markers to Predict Endometrial Cancer Outcome. International Journal of Gynecological Cancer. 20(3). 363–367. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026